South Carolina 2025-2026 Regular Session

South Carolina Senate Bill S0544 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	South Carolina General Assembly126th Session, 2025-2026
2	2
3	3	Bill 544
4	4
5	5	Indicates Matter StrickenIndicates New Matter
6	6
7	7	(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)
8	8
9	9	A senate RESOLUTION TO ENCOURAGE EACH INDIVIDUAL IN SOUTH CAROLINA TO BECOME BETTER INFORMED ABOUT AND AWARE OF KIDNEY DISEASE AND APOL1-MEDIATED KIDNEY DISEASE, TO ENCOURAGE PEOPLE FROM OR WITH ANCESTRY FROM WESTERN AND CENTRAL AFRICA TO CONSIDER GENETIC TESTING FOR APOL1 GENE MUTATIONS, AND TO DECLARE TUESDAY, APRIL 29, 2025, AS "APOL1-MEDIATED KIDNEY DISEASE AWARENESS DAY" IN THE STATE OF SOUTH CAROLINA. Whereas, kidney disease affects an estimated thirty-seven million Americans, and more than five-hundred-fifty thousand are on dialysis. African Americans with kidney disease are more likely to develop kidney failure than any other racial or ethnic group; and Whereas, the health disparities in kidney failure are unsustainable, with Black people making up thirteen percent of the United States population but accounting for thirty-five percent of those with kidney failure. Kidney failure places enormous physical, emotional, and financial burdens on individuals and costs the Medicare program over fifty billion dollars annually; and Whereas, there are genetic factors that can increase an individual's risk for kidney disease. One such genetic factor is having variants, that is mutations, in the apolipoprotein L1 (APOL1) gene. People are more likely to have APOL1 gene variants if they are from Western or Central Africa or have an ancestor who came from these regions; and Whereas, these variants can increase susceptibility for APOL1-mediated kidney disease (AMKD), a rapidly progressive form of kidney disease that can lead to kidney failure; and Whereas, it is estimated that if a patient has variants in both copies of the APOL1 gene, there is a one-in-five chance they will go on to develop kidney disease, and an estimated thirteen percent of African Americans have variants in both copies of the APOL1 gene; and Whereas, a person with AMKD may not have any symptoms of kidney disease until their kidneys are close to failing, but genetic testing can reveal the risk individuals may have for AMKD, empowering them to take the steps necessary to protect their kidney health before it is too late; and Whereas, individuals who are found to have APOL1 genetic variants can reduce their risk for kidney failure by meeting with their doctor regularly, eating a healthy diet, taking all medications as prescribed, exercising for at least thirty minutes a day, and not smoking or using tobacco; and Whereas, additional awareness and research of APOL1 genetic mutations are needed to improve understanding of the kidney disease disparities in the population; and Whereas, there are currently no FDA-approved treatments available for APOL1-mediated kidney disease, but clinical trials could provide an opportunity for researchers to develop and test safe treatments for APOL1-mediated kidney disease. Now, therefore, Be it resolved by the Senate: That the members of the South Carolina Senate, by this resolution, encourage each individual in South Carolina to become better informed about and aware of kidney disease and APOL1-mediated kidney disease, encourage people from or with ancestry from Western and Central Africa to consider genetic testing for APOL1 gene mutations, and declare Tuesday, April 29, 2025, as "APOL1-Mediated Kidney Disease Awareness Day" in the State of South Carolina. ----XX----
10	10
11	11
12	12
13	13
14	14
15	15	A senate RESOLUTION
16	16
17	17
18	18
19	19	TO ENCOURAGE EACH INDIVIDUAL IN SOUTH CAROLINA TO BECOME BETTER INFORMED ABOUT AND AWARE OF KIDNEY DISEASE AND APOL1-MEDIATED KIDNEY DISEASE, TO ENCOURAGE PEOPLE FROM OR WITH ANCESTRY FROM WESTERN AND CENTRAL AFRICA TO CONSIDER GENETIC TESTING FOR APOL1 GENE MUTATIONS, AND TO DECLARE TUESDAY, APRIL 29, 2025, AS "APOL1-MEDIATED KIDNEY DISEASE AWARENESS DAY" IN THE STATE OF SOUTH CAROLINA.
20	20
21	21
22	22
23	23	Whereas, kidney disease affects an estimated thirty-seven million Americans, and more than five-hundred-fifty thousand are on dialysis. African Americans with kidney disease are more likely to develop kidney failure than any other racial or ethnic group; and
24	24
25	25
26	26
27	27	Whereas, the health disparities in kidney failure are unsustainable, with Black people making up thirteen percent of the United States population but accounting for thirty-five percent of those with kidney failure. Kidney failure places enormous physical, emotional, and financial burdens on individuals and costs the Medicare program over fifty billion dollars annually; and
28	28
29	29
30	30
31	31	Whereas, there are genetic factors that can increase an individual's risk for kidney disease. One such genetic factor is having variants, that is mutations, in the apolipoprotein L1 (APOL1) gene. People are more likely to have APOL1 gene variants if they are from Western or Central Africa or have an ancestor who came from these regions; and
32	32
33	33
34	34
35	35	Whereas, these variants can increase susceptibility for APOL1-mediated kidney disease (AMKD), a rapidly progressive form of kidney disease that can lead to kidney failure; and
36	36
37	37
38	38
39	39	Whereas, it is estimated that if a patient has variants in both copies of the APOL1 gene, there is a one-in-five chance they will go on to develop kidney disease, and an estimated thirteen percent of African Americans have variants in both copies of the APOL1 gene; and
40	40
41	41
42	42
43	43	Whereas, a person with AMKD may not have any symptoms of kidney disease until their kidneys are close to failing, but genetic testing can reveal the risk individuals may have for AMKD, empowering them to take the steps necessary to protect their kidney health before it is too late; and
44	44
45	45
46	46
47	47	Whereas, individuals who are found to have APOL1 genetic variants can reduce their risk for kidney failure by meeting with their doctor regularly, eating a healthy diet, taking all medications as prescribed, exercising for at least thirty minutes a day, and not smoking or using tobacco; and
48	48
49	49
50	50
51	51	Whereas, additional awareness and research of APOL1 genetic mutations are needed to improve understanding of the kidney disease disparities in the population; and
52	52
53	53
54	54
55	55	Whereas, there are currently no FDA-approved treatments available for APOL1-mediated kidney disease, but clinical trials could provide an opportunity for researchers to develop and test safe treatments for APOL1-mediated kidney disease. Now, therefore,
56	56
57	57
58	58
59	59	Be it resolved by the Senate:
60	60
61	61
62	62
63	63	That the members of the South Carolina Senate, by this resolution, encourage each individual in South Carolina to become better informed about and aware of kidney disease and APOL1-mediated kidney disease, encourage people from or with ancestry from Western and Central Africa to consider genetic testing for APOL1 gene mutations, and declare Tuesday, April 29, 2025, as "APOL1-Mediated Kidney Disease Awareness Day" in the State of South Carolina.
64	64
65	65
66	66
67	67	----XX----
68	68
69	69	This web page was last updated on April 03, 2025 at 11:59 AM